ORAMED PHARMACEUTICALS INC. (ORMP)

SEC filing

ORAMED PHARMACEUTICALS INC.

ORMP · CIK 1176309

4 · Sep 25, 2026 · Director, President and CEO KIDRON NADAV was granted 718.26K shares; reported 789.50K Stock option (right to buy)

Director, President and CEO KIDRON NADAV was granted 718.26K shares; reported 789.50K Stock option (right to buy)

Could not load the primary document from EDGAR (SEC rate limit, timeout, or temporary upstream error). Refresh in a minute, or use View on SEC.gov.